BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2695331)

  • 1. Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections.
    Bayer AS
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1102-10. PubMed ID: 2695331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones.
    Rissing JP
    Clin Infect Dis; 1997 Dec; 25(6):1327-33. PubMed ID: 9431371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the new quinolones in cystic fibrosis.
    Grenier B
    Rev Infect Dis; 1989; 11 Suppl 5():S1245-52. PubMed ID: 2672252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review.
    Norrby SR
    Scand J Infect Dis Suppl; 1989; 60():74-8. PubMed ID: 2667110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fluoroquinolones in respiratory tract infections.
    Grossman RF
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():59-62. PubMed ID: 9484874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
    Fong IW
    Clin Invest Med; 1989 Feb; 12(1):44-9. PubMed ID: 2646054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolones in the treatment of lower respiratory tract infections.
    Thys JP; Jacobs F; Motte S
    Rev Infect Dis; 1989; 11 Suppl 5():S1212-9. PubMed ID: 2672250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of quinolones for the treatment of osteomyelitis and septic arthritis.
    Waldvogel FA
    Rev Infect Dis; 1989; 11 Suppl 5():S1259-63. PubMed ID: 2672253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli.
    Gilbert DN; Tice AD; Marsh PK; Craven PC; Preheim LC
    Am J Med; 1987 Apr; 82(4A):254-8. PubMed ID: 3555044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of quinolones in osteomyelitis and infected orthopaedic prosthesis.
    Lew DP; Waldvogel FA
    Drugs; 1999; 58 Suppl 2():85-91. PubMed ID: 10553713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
    Greenberg RN; Newman MT; Shariaty S; Pectol RW
    Antimicrob Agents Chemother; 2000 Jan; 44(1):164-6. PubMed ID: 10602739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Drugeon HB
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1024-30. PubMed ID: 2515961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of quinolones in pediatrics.
    Schaad UB
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):355-60. PubMed ID: 1864297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of plasmid-mediated quinolone resistance in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients].
    Coban AY; Tanrıverdi Çaycı Y; Yıldırım T; Erturan Z; Durupınar B; Bozdoğan B
    Mikrobiyol Bul; 2011 Oct; 45(4):602-8. PubMed ID: 22090290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New quinolones in the treatment of joint and bone infections.
    Desplaces N; Acar JF
    Rev Infect Dis; 1988; 10 Suppl 1():S179-83. PubMed ID: 3279491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of fluoroquinolones in lower respiratory tract infections.
    Vellend H
    Clin Invest Med; 1989 Feb; 12(1):39-43. PubMed ID: 2920482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.